MiR-29 silencing modulates the expression of target genes related to proliferation, apoptosis and methylation in Burkitt lymphoma cells

miR-17-92 cluster components analysis in Burkitt lymphoma: overexpression of miR-17 is associated with poor prognosis

(2016) Marcela Cristina Robaina et al.   ANNALS OF HEMATOLOGY

A Kinase-Independent Function of CDK6 Links the Cell Cycle to Tumor Angiogenesis

(2016) Karoline Kollmann et al.   CANCER CELL

MiR-29b suppresses the proliferation and migration of osteosarcoma cells by targeting CDK6

(2016) Kegan Zhu et al.   Protein & Cell

Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation

(2015) Giulia De Falco et al.   BMC CANCER

Potential roles of microRNA-29a in the molecular pathophysiology of T-cell acute lymphoblastic leukemia

(2015) Lucila H. Oliveira et al.   CANCER SCIENCE

Deregulation of DNMT1, DNMT3B and miR-29s in Burkitt lymphoma suggests novel contribution for disease pathogenesis

(2015) Marcela C. Robaina et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

MicroRNAs mediated targeting on the Yin-yang dynamics of DNA methylation in disease and development

(2015) Jiajie Tu et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Quantitative analysis of CDKN2A methylation, mRNA, and p16INK4a protein expression in children and adolescents with Burkitt lymphoma: Biological and clinical implications

(2015) Marcela Cristina S. Robaina et al.   LEUKEMIA RESEARCH

The role of miR-29b in cancer: regulation, function, and signaling

(2015) Jin-Rui Yang et al.   OncoTargets and Therapy

miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies

(2015) Nicola Amodio et al.   Oncotarget

Deregulation between miR-29b/c and DNMT3A Is Associated with Epigenetic Silencing of the CDH1 Gene, Affecting Cell Migration and Invasion in Gastric Cancer

(2015) He Cui et al.   PLoS One

Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter

(2015) Elizabeth Poli et al.   PLoS One

A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma

(2014) I. Salaverria et al.   BLOOD

Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma

(2014) J. Iqbal et al.   BLOOD

Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53

(2014) G. L. Kelly et al.   GENES & DEVELOPMENT

Translocation t(2;7)(p11;q21) associated with the CDK6/IGK rearrangement is a rare but recurrent abnormality in B-cell lymphoproliferative malignancies

(2014) Nathalie Douet-Guilbert et al.   Cancer Genetics

MYC and the Art of MicroRNA Maintenance

(2014) J. N. Psathas et al.   Cold Spring Harbor Perspectives in Medicine

Ten-eleven translocation (Tet) and thymine DNA glycosylase (TDG), components of the demethylation pathway, are direct targets of miRNA-29a

(2013) Pei Zhang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

(2013) S. Hu et al.   BLOOD

Programming cancer cells for high expression levels of Mcl1

(2013) Franziska Ertel et al.   EMBO REPORTS

miR-29 Represses the Activities of DNA Methyltransferases and DNA Demethylases

(2013) Sumiyo Morita et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Protooncogene TCL1b functions as an Akt kinase co-activator that exhibits oncogenic potency in vivo

(2013) M Hashimoto et al.   Oncogenesis

Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes

(2012) L. Giulino-Roth et al.   BLOOD

Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas

(2012) Xinwei Zhang et al.   CANCER CELL

Roles for MicroRNAs in Conferring Robustness to Biological Processes

(2012) Margaret S. Ebert et al.   CELL

MYC on the Path to Cancer

(2012) Chi V. Dang   CELL

miRNAs and cancer: An epigenetics view

(2012) Marcos Malumbres   MOLECULAR ASPECTS OF MEDICINE

MicroRNA and cancer

(2012) Martin D. Jansson et al.   Molecular Oncology

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

(2011) E. Campo et al.   BLOOD

Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expression

(2011) Joshua D. Schiffman et al.   BRITISH JOURNAL OF HAEMATOLOGY

The tumor suppressor microRNA-101 becomes an epigenetic player by targeting the Polycomb group protein EZH2 in cancer

(2011) Jeffrey M. Friedman et al.   CELL CYCLE

Epigenetic regulation of microRNAs in cancer: An integrated review of literature

(2011) Tanja Kunej et al.   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS

Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7

(2011) Ingrid E. Wertz et al.   NATURE

Methylation of an intronic region regulates miR-199a in testicular tumor malignancy

(2011) H-H Cheung et al.   ONCOGENE

DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer

(2011) P Lopez-Serra et al.   ONCOGENE

microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma

(2010) J.-J. Zhao et al.   BLOOD

Transcriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-kappaB

(2010) Justin L. Mott et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia

(2010) Yoon-Chi Han et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression

(2010) U. Santanam et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1

(2009) R. Garzon et al.   BLOOD

MicroRNAs: Target Recognition and Regulatory Functions

(2009) David P. Bartel   CELL

miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis

(2009) Christoph A Gebeshuber et al.   EMBO REPORTS

Effects of MicroRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma

(2009) Yujuan Xiong et al.   HEPATOLOGY

c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism

(2009) Ping Gao et al.   NATURE

miR-449a targets HDAC-1 and induces growth arrest in prostate cancer

(2009) E J Noonan et al.   ONCOGENE

Burkitt Lymphoma in Brazil Is Characterized by Geographically Distinct Clinicopathologic Features

(2008) Eduardo M. Queiroga et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Epigenetic Silencing of MicroRNA-34b/c and B-Cell Translocation Gene 4 Is Associated with CpG Island Methylation in Colorectal Cancer

(2008) M. Toyota et al.   CANCER RESEARCH

miR-29 miRNAs activate p53 by targeting p85α and CDC42

(2008) Seong-Yeon Park et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins

(2008) S. Sengupta et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Epigenetic inactivation of microRNA genehsa-mir-9-1in human breast cancer

(2007) U Lehmann et al.   JOURNAL OF PATHOLOGY

The BCL-2 protein family: opposing activities that mediate cell death

(2007) Richard J. Youle et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY